NCT01902173 2025-01-14
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Barbara Ann Karmanos Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
University of Pittsburgh
Groupe Oncologie Radiotherapie Tete et Cou